News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
689,376 Results
Type
Article (40767)
Company Profile (281)
Press Release (648328)
Section
Business (204365)
Career Advice (2032)
Deals (35435)
Drug Delivery (85)
Drug Development (81070)
Employer Resources (169)
FDA (16183)
Job Trends (14851)
News (345553)
Policy (32610)
Tag
Academia (2575)
Alliances (49230)
Alzheimer's disease (1234)
Approvals (16113)
Artificial intelligence (130)
Bankruptcy (352)
Best Places to Work (11563)
Biotechnology (201)
Breast cancer (121)
Cancer (1090)
Cardiovascular disease (99)
Career advice (1697)
Cell therapy (233)
Clinical research (64407)
Collaboration (388)
Compensation (197)
COVID-19 (2546)
C-suite (95)
Data (1121)
Diabetes (152)
Diagnostics (6153)
Earnings (84929)
Employer resources (147)
Events (109841)
Executive appointments (308)
FDA (16716)
Funding (349)
Gene therapy (178)
GLP-1 (579)
Government (4354)
Healthcare (18738)
Infectious disease (2632)
Inflammatory bowel disease (106)
Interviews (318)
IPO (16316)
Job creations (3642)
Job search strategy (1446)
Layoffs (417)
Legal (7891)
Lung cancer (173)
Manufacturing (180)
Medical device (13231)
Medtech (13236)
Mergers & acquisitions (19195)
Metabolic disorders (404)
Neuroscience (1512)
NextGen Class of 2024 (6535)
Non-profit (4498)
Northern California (1478)
Obesity (233)
Opinion (186)
Patents (102)
People (56422)
Phase I (20008)
Phase II (28369)
Phase III (21158)
Pipeline (455)
Postmarket research (2563)
Preclinical (8547)
Radiopharmaceuticals (236)
Rare diseases (219)
Real estate (5920)
Regulatory (21632)
Research institute (2333)
Resumes & cover letters (357)
Southern California (1298)
Startups (3581)
United States (13453)
Vaccines (549)
Weight loss (168)
Date
Today (119)
Last 7 days (802)
Last 30 days (3803)
Last 365 days (35690)
2024 (32725)
2023 (40140)
2022 (51269)
2021 (55841)
2020 (54237)
2019 (46724)
2018 (35187)
2017 (32288)
2016 (31725)
2015 (37789)
2014 (31550)
2013 (26644)
2012 (28872)
2011 (29546)
2010 (27562)
Location
Africa (723)
Arizona (192)
Asia (37383)
Australia (6108)
California (3321)
Canada (1286)
China (249)
Colorado (144)
Connecticut (152)
Europe (80275)
Florida (459)
Georgia (117)
Illinois (341)
Indiana (196)
Kansas (96)
Maryland (576)
Massachusetts (2605)
Michigan (157)
Minnesota (272)
New Jersey (953)
New York (957)
North Carolina (701)
Northern California (1478)
Ohio (139)
Pennsylvania (842)
South America (1103)
Southern California (1298)
Texas (461)
Utah (91)
Washington State (359)
689,376 Results for "berkeley lights inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
AbCellera Announces that the U.S. Patent Trial and Appeal Board Has Denied Berkeley Lights’ Request for Rehearing
AbCellera (Nasdaq: ABCL) announced that the United States Patent and Trademark Office’s (USPTO) Patent Trial and Appeal Board (PTAB) has denied a rehearing request in an Inter Partes Review (IPR) filed by Berkeley Lights, Inc. (Berkeley Lights) that challenged AbCellera’s U.S. Patent No. 10,087,408 (the ‘408 Patent).
July 24, 2023
·
4 min read
Business
Berkeley Lights Reports Fourth Quarter and Full Year 2022 Financial Results
Berkeley Lights, Inc. (Nasdaq: BLI), a life sciences tools company, today reported financial results for the fourth quarter and full year ended December 31, 2022.
February 23, 2023
·
11 min read
Deals
Berkeley Lights Completes Acquisition of IsoPlexis Forming PhenomeX, the Functional Cell Biology Company
Berkeley Lights, Inc. (Nasdaq: BLI), a life sciences tools company, today announced that it has completed its previously announced acquisition of IsoPlexis Corporation (Nasdaq: ISO), a company empowering labs to leverage the cells and proteome.
March 21, 2023
·
6 min read
Deals
Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company
Berkeley Lights and IsoPlexis announced a definitive agreement under which Berkeley Lights will acquire IsoPlexis in an all-stock transaction valued at $57.8 million.
December 21, 2022
·
14 min read
Business
Berkeley Lights Reports Third Quarter 2022 Financial Results
Berkeley Lights, Inc., a leader in digital cell biology, reported financial results for the quarter ended September 30, 2022.
November 8, 2022
·
7 min read
Genetown
Biofrontera Announces the Launch of a New, FDA-Approved Red Light Source, the RhodoLED® XL Lamp
Biofrontera Inc. (NASDAQ: BFRI), a biopharmaceutical company specializing in the commercialization of dermatologic products, is proud to announce the launch of its FDA-approved RhodoLED XL, a red light emitting LED lamp.
June 24, 2024
·
5 min read
Biotech Bay
Berkeley Lights Launches Beacon Select™, A New Optofluidic System For Cell Line Development
Berkeley Lights, Inc., a life sciences tools company, announced the launch of the Beacon Select™, the company’s new optofluidic system for cell line development.
January 9, 2023
·
4 min read
Biotech Bay
Berkeley Lights to Participate in the 41st Annual J.P. Morgan Healthcare Conference
Berkeley Lights, Inc., a life sciences tools company, announced the Company will be participating in the upcoming 41st Annual J.P. Morgan Healthcare Conference.
January 3, 2023
·
2 min read
Business
Berkeley Lights to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
Berkeley Lights, Inc., a life sciences tools company, announced that the Company will be reporting financial results for the fourth quarter and full year 2022 after market on Thursday, February 23, 2023.
February 13, 2023
·
2 min read
BioMidwest
DNA Nanobots Gains Exclusive License to UC Berkeley Gene Editing Technology Platform for Non-Viral Gene Delivery Solution using DNA Nanoparticles and CRISPR-Cas
DNA Nanobots, a biotechnology leader in DNA nanoparticles engineered for targeted therapeutics, announced that it completed exclusive commercial licensing of a gene editing technology from the University of California Berkeley.
June 5, 2024
·
2 min read
1 of 68,938
Next
